Chagas Disease: all 73 studies
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Assessment of the Risk of Zoonotic Infections in Prisons in French GuianaNot yet recruitingNCT07808775
- A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.RecruitingNCT06632600Phase 2
- An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's HealthNot yet recruitingNCT05477953
- Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseRecruitingNCT04897516Phase 3
- Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.RecruitingNCT04853758Phase 3
- Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCCCompletedNCT04023227Phase 4Results posted
- Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive AgeCompletedNCT03672487Phase 3Results posted
- A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma CruziCompletedNCT02625974Phase 3Results posted
- Assessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas DiseaseCompletedNCT02327052Results posted
- Abbott ESA Chagas Assay Post-Market StudyCompletedNCT01662362Not applicableResults posted
- A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)CompletedNCT01377480Phase 2Results posted
- A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy SubjectsCompletedNCT07809919Phase 1
- University-Based Chagas Testing in Salta Province, ArgentinaCompletedNCT07033325
- First-in-Human Trial of Oral AN2-502998CompletedNCT07024589Phase 1
- Cardiac Mechanics by Speckle Tracking As a Prognostic Predictor in Patients with Chagas CardiomyopathyCompletedNCT06806722
- Short Benznidazole Regimen for Chronic Phase Chagas Disease PatientsWithdrawnNCT06339710Phase 3
- Delivering a Multi-disease Screening Tool to Migrant PopulationsCompletedNCT05868005Not applicable
- Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas DiseaseTerminatedNCT04984616Phase 2
- SBRT in Chagas Disease Ventricular TachycardiaActive, not recruitingNCT04984265Phase 1/2
- Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease TreatmentStatus unknownNCT04274101
- Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas DiseaseCompletedNCT04239144Not applicable
- Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated ChildrenCompletedNCT04090489
- Implementation Strategy of Bio-molecular Techniques for Early Diagnose of Congenital Syphilis and Chagas DiseasesStatus unknownNCT04084379
- Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas DiseaseActive, not recruitingNCT04024163Phase 3
- New Therapies and Biomarkers for Chagas InfectionCompletedNCT03981523Phase 2
- Pharmacokinetic Drug-Drug Interaction StudyCompletedNCT03892213Phase 1
- Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in ArgentinaCompletedNCT03784391
- Colchicine for Patients With Chagas´ Disease( B1 Stage)Status unknownNCT03704181Phase 2
- Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas DiseaseCompletedNCT03587766Phase 2
- BENDITA BEnznidazole New Doses Improved Treatment and AssociationsStatus unknownNCT03378661Phase 2
- Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mgCompletedNCT03350295Phase 1
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits StudyCompletedNCT03334838Phase 1
- A Trial Testing Amiodarone in Chagas CardiomiopathyStatus unknownNCT03193749Phase 3
- Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.CompletedNCT03191162Phase 2
- Lower Urinary Tract Dysfunction in Chronic Chagas' Disease : Clinical and Urodynamic PresentationCompletedNCT03189056
- Longitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project)CompletedNCT02646943
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' PatientsCompletedNCT02606864Phase 1
- Physical Exercise Program in Chronic Chagas Heart DiseaseCompletedNCT02517632Phase 3
- Cardiac Rehabilitation in Chagas Heart FailureCompletedNCT02516293Phase 2/3
- Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas DiseaseStatus unknownNCT02498782Phase 2
- Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical TrialCompletedNCT02386358Phase 3
- CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)Status unknownNCT02369978Phase 2/3
- Determination of Genetic Polymorphisms in Chronic Chagas CardiomyopathyCompletedNCT02346123
- Exercise Training in Patients With Chagasic Heart Disease Without Ventricular DysfunctionStatus unknownNCT02295215Not applicable
- Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas CardiomyopathyCompletedNCT02154269Phase 2
- Renal Denervation in Patients With Heart Failure Secondary to Chagas DiseaseStatus unknownNCT02099903Not applicable
- Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' PatientsCompletedNCT01927224Phase 1
- Effect of Ganglionar Electrical Stimulation on Central Arterial PressureCompletedNCT01874795Not applicable
- Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas CardiomyopathyCompletedNCT01863576Early Phase 1
- Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular TachycardiasStatus unknownNCT01847378
- MicroRNAs as Biomarkers in Patients With Chagas DiseaseCompletedNCT01842880
- Syndecan-4 as a Biomarker in Patients With Chagas DiseaseCompletedNCT01842867
- Galectin-3 as a Biomarker in Patients With Chagas DiseaseCompletedNCT01842854
- Congenital Transmission of Lineages I and II of Trypanosoma CruziCompletedNCT01787968
- Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas DiseaseCompletedNCT01755403Phase 4
- New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas DiseaseCompletedNCT01755377
- Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas DiseaseCompletedNCT01744405
- Improving Blood Safety and HIV Testing in BrazilCompletedNCT01681420Not applicable
- Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas DiseaseCompletedNCT01678599Phase 4
- Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)Status unknownNCT01650792Phase 4
- Population Pharmacokinetics Study of Benznidazole in Children With Chagas'DiseaseCompletedNCT01549236Phase 4
- Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas DiseaseCompletedNCT01547533
- Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas DiseaseTerminatedNCT01539161Phase 4
- Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas DiseaseStatus unknownNCT01489228Phase 2
- Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And BenznidazoleCompletedNCT01162967Phase 2
- Outcomes of an Anticoagulation Clinic in an University HospitalCompletedNCT01006486Phase 4
- Exercise Training in Chagas CardiomyopathyCompletedNCT01006473Phase 4
- Selenium Treatment and Chagasic Cardiopathy (STCC)Status unknownNCT00875173Phase 3
- Population Pharmacokinetics of Benznidazole in Children With Chagas DiseaseCompletedNCT00699387Not applicable
- Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on ElectrocardiogramCompletedNCT00453700
- BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' DiseaseCompletedNCT00123916Phase 3
- Genetic Architecture of Heart Disease in Rural BrazilCompletedNCT00023556
- Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United StatesCompletedNCT00005455